Screening for celiac disease in the general population and in high-risk groups

United European Gastroenterology Journal

Volumn 3, Issue 2, 2015, Pages 106-120

  Ludvigsson, Jonas F ^a,b   Card, Timothy R ^c   Kaukinen, Katri ^d,e,f   Bai, Julio ^g   Zingone, Fabiana ^h   Sanders, David S ⁱ   Murray, Joseph A ^j  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^e TAMPERE UNIVERSITY HOSPITAL   (Finland)

^f SEINÄJOKI CENTRAL HOSPITAL   (Finland)

^g UNIVERSIDAD DEL SALVADOR   (Argentina)

^h UNIVERSITY OF SALERNO   (Italy)

ⁱ ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^j MAYO GRADUATE SCHOOL   (United States)

more..

Author keywords

Celiac disease; Gluten; Gluten free diet; Prevention; Quality of life; Review; Risk; Screening; World health organization

Indexed keywords

AUTOIMMUNITY; BONE MINERALIZATION; CELIAC DISEASE; COST EFFECTIVENESS ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; IRON DEFICIENCY ANEMIA; MASS SCREENING; OSTEOMALACIA; OSTEOPOROSIS; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SENSITIVITY AND SPECIFICITY; WORLD HEALTH ORGANIZATION;

EID: 84981194134     PISSN: 20506406     EISSN: 20506414     Source Type: Journal    
DOI: 10.1177/2050640614561668     Document Type: Review

References (157)

1. Maki M, Mustalahti K, Kokkonen J, et al. Prevalence of celiac disease among children in Finland. N Engl J Med 2003; 348: 2517–2524.
2. Walker MM, Murray JA, Ronkainen J, et al. Detection of celiac disease and lymphocytic enteropathy by parallel serology and histopathology in a population-based study. Gastroenterology 2010; 139: 112–119.
3. Mustalahti K, Catassi C, Reunanen A, et al. The prevalence of celiac disease in Europe: Results of a centralized, international mass screening project. Ann Med 2010; 42: 587–595.
4. Murray JA, Van Dyke C, Plevak MF, et al. Trends in the identification and clinical features of celiac disease in a North American community, 1950–2001. Clin Gastroenterol Hepatol 2003; 1: 19–27.
5. Lohi S, Mustalahti K, Kaukinen K, et al. Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther 2007; 26: 1217–1225.
6. Rubio-Tapia A, Kyle RA, Kaplan EL, et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology 2009; 137: 88–93.
7. Catassi C, Kryszak D, Bhatti B, et al. Natural history of celiac disease autoimmunity in a US cohort followed since 1974. Ann Med 2010; 42: 530–538.
8. Ludvigsson JF, Montgomery SM, Ekbom A, et al. Smallintestinal histopathology and mortality risk in celiac disease. JAMA 2009; 302: 1171–1178.
9. Burgin-Wolff A, Gaze H, Hadziselimovic F, et al. Antigliadin and antiendomysium antibody determination for coeliac disease. Arch Dis Child 1991; 66: 941–947.
10. Ladinser B, Rossipal E and Pittschieler K. Endomysium antibodies in coeliac disease: An improved method. Gut 1994; 35: 776–778.
11. Dieterich W, Ehnis T, Bauer M, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997; 3: 797–801.
12. Dieterich W, Laag E, Schopper H, et al. Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology 1998; 115: 1317–1321.
13. Du8be C, Rostom A, Sy R, et al. The prevalence of celiac disease in average-risk and at-risk Western European populations: A systematic review. Gastroenterology 2005; 128: 57–67.
14. Ludvigsson JF, Bai JC, Biagi F, et al. Diagnosis and management of adult coeliac disease: Guidelines from the British Society of Gastroenterology. Gut 2013; 62: 43–52.
15. Ludvigsson JF, Leffler DA, Bai JC, et al. The Oslo definitions for coeliac disease and related terms. Gut 2013; 62: 43–52.
16. Fasano A, Berti I, Gerarduzzi T, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: A large multicenter study. Arch Intern Med 2003; 163: 286–292.
17. Rubio-Tapia A, Ludvigsson JF, Brantner TL, et al. The prevalence of celiac disease in the United States. Am J Gastroenterol 2012; 107: 1538–1544.
18. Myleus A, Ivarsson A, Webb C, et al. Celiac disease revealed in 3% of Swedish 12-year-olds born during an epidemic. J Pediatr Gastroenterol Nutr 2009; 49: 170–176.
19. Remes-Troche JM, Ramirez-Iglesias MT, Rubio-Tapia A, et al. Celiac disease could be a frequent disease in Mexico: Prevalence of tissue transglutaminase antibody in healthy blood donors. J Clin Gastroenterol 2006; 40:697–700.
20. Gomez JC, Selvaggio GS, Viola M, et al. Prevalence of celiac disease in Argentina: Screening of an adult population in the La Plata area. Am J Gastroenterol 2001; 96: 2700–2704.
21. Catassi C, Ratsch IM, Gandolfi L, et al. Why is coeliac disease endemic in the people of the Sahara? Lancet 1999; 354: 647–648.
22. Biesiekierski JR, Newnham ED, Irving PM, et al. Gluten causes gastrointestinal symptoms in subjects without celiac disease: A double-blind randomized placebo- controlled trial. Am J Gastroenterol 2011; 106: 508–514.
23. Catassi C, Bai JC, Bonaz B, et al. Non-celiac gluten sensitivity: The new frontier of gluten related disorders. Nutrients 2013; 5: 3839–3853.
24. Elfstrom P, Granath F, Ekstrom Smedby K, et al. Risk of lymphoproliferative malignancy in relation to small intestinal histopathology among patients with celiac disease. J Natl Cancer Inst 2011; 103: 436–444.
25. Hill ID. What are the sensitivity and specificity of serologic tests for celiac disease? Do sensitivity and specificity vary in different populations? Gastroenterology 2005; 128: 25–32.
26. Villalta D, Crovatto M, Stella S, et al. False positive reactions for IgA and IgG anti-tissue transglutaminase antibodies in liver cirrhosis are common and methoddependent. Clin Chim Acta 2005; 356: 102–109.
27. Ferrara F, Quaglia S, Caputo I, et al. Anti-transglutaminase antibodies in non-coeliac children suffering from infectious diseases. Clin Exp Immunol 2010; 159: 217–223.
28. De Bem RS, Da Ro Sa Utiyama SR, Nisihara RM, et al. Celiac disease prevalence in Brazilian dilated cardiomyopathy patients. Dig Dis Sci 2006; 51: 1016–1019.
29. Di Tola M, Barilla F, Trappolini M, et al. Antitissue transglutaminase antibodies in acute coronary syndrome: An alert signal of myocardial tissue lesion? J Intern Med 2008; 263: 43–51.
30. Rostom A, Dube C, Cranney A, et al. The diagnostic accuracy of serologic tests for celiac disease: A systematic review. Gastroenterology 2005; 128: 38–46.
31. Lewis NR and Scott BB. Meta-analysis: Deamidated gliadin peptide antibody and tissue transglutaminase antibody compared as screening tests for coeliac disease. Aliment Pharmacol Ther 2010; 31: 73–81.
32. Hopper AD, Cross SS, Hurlstone DP, et al. Pre-endoscopy serological testing for coeliac disease: Evaluation of a clinical decision tool. Brit Med J 2007; 334: 729.
33. Katz KD, Rashtak S, Lahr BD, et al. Screening for celiac disease in a North American population: sequential serology and gastrointestinal symptoms. Am J Gastroenterol 2011; 106: 1333–1339.
34. Sugai E, Moreno ML, Hwang HJ, et al. Celiac disease serology in patients with different pretest probabilities: Is biopsy avoidable? World J Gastroenterol 2010; 16: 3144–3152.
35. Van Meensel B, Hiele M, Hoffman I, et al. Diagnostic accuracy of ten second-generation (human) tissue transglutaminase antibody assays in celiac disease. Clin Chem 2004; 50: 2125–2135.
36. Wong RC, Wilson RJ, Steele RH, et al. A comparison of 13 guinea pig and human anti-tissue transglutaminase antibody ELISA kits. J Clin Pathol 2002; 55: 488–494.
37. Reeves GE, Squance ML, Duggan AE, et al. Diagnostic accuracy of coeliac serological tests: A prospective study. Eur J Gastroenterol Hepatol 2006; 18: 493–501.
38. Pinkas DM, Strop P, Brunger AT, et al.Transglutaminase 2 undergoes a large conformational change upon activation. PLoS Biol 2007; 5: e327.
39. Lindfors K, Koskinen O, Kurppa K, et al. Serodiagnostic assays for celiac disease based on the open or closed conformation of the autoantigen, transglutaminase 2. J Clin Immunol 2011; 31: 436–442.
40. Walker MM and Murray JA. An update in the diagnosis of coeliac disease. Histopathology 2010; 59: 166–179.
41. Esteve M, Rosinach M, Fernandez-Banares F, et al. Spectrum of gluten-sensitive enteropathy in first-degree relatives of patients with coeliac disease: Clinical relevance of lymphocytic enteritis. Gut 2006; 55: 1739–1745.
42. Fairhead J, Leach M and Small M. Where techno-science meets poverty: Medical research and the economy of blood in The Gambia, West Africa. Soc Sci Med 2006; 63: 1109–1120.
43. Murray JA, Watson T, Clearman B, et al. Effect of a gluten-free diet on gastrointestinal symptoms in celiac disease. Am J Clin Nutr 2004; 79: 669–673.
44. Holmes GK, Prior P, Lane MR, et al. Malignancy in coeliac disease: Effect of a gluten free diet. Gut 1989; 30: 333–338.
45. Sanchez MI, Mohaidle A, Baistrocchi A, et al. Risk of fracture in celiac disease: Gender, dietary compliance, or both? World J Gastroenterol 2011; 17: 3035–3042.
46. Johnston SD, Rodgers C and Watson RG. Quality of life in screen-detected and typical coeliac disease and the effect of excluding dietary gluten. Eur J Gastroenterol Hepatol 2004; 16: 1281–1286.
47. Korponay-Szabo IR, Szabados K, Pusztai J, et al. Population screening for coeliac disease in primary care by district nurses using a rapid antibody test: Diagnostic accuracy and feasibility study. Brit Med J 2007; 335: 1244–1247.
48. Whitaker JK, West J, Holmes GK, et al. Patient perceptions of the burden of coeliac disease and its treatment in the UK. Aliment Pharmacol Ther 2009; 29: 1131–1136.
49. Ukkola A, Maki M, Kurppa K, et al. Patients’ experiences and perceptions of living with coeliac disease: Implications for optimizing care. J Gastrointest Liver Dis 2012; 21: 17–22.
50. Nordyke K, Norstrom F, Lindholm L, et al. Healthrelated quality-of-life in children with coeliac disease, measured prior to receiving their diagnosis throughscreening. J Med Screen 2011; 18: 187–192.
51. Johnston SD, Watson RG, McMillan SA, et al. Coeliac disease detected by screening is not silent -simply unrecognized. QJM 1998; 91: 853–860.
52. Van Koppen EJ, Schweizer JJ, Csizmadia CG, et al. Long-term health and quality-of-life consequences of mass screening for childhood celiac disease: A 10-year follow-up study. Pediatrics 2009; 123: e582–588.
53. Ukkola A, Maki M, Kurppa K, et al. Diet improves perception of health and well-being in symptomatic, but not asymptomatic, patients with celiac disease. Clin Gastroenterol Hepatol 2011; 9: 118–123.
54. Rosen A, Ivarsson A, Nordyke K, et al. Balancing health benefits and social sacrifices: A qualitative study of how screening-detected celiac disease impacts adolescents’ quality of life. BMC Pediatr 2011; 11: 32.
55. Kurppa K, Paavola A, Collin P, et al. Benefits of a gluten-free diet for asymptomatic patients with serologic markers of celiac disease. Gastroenterology 2014; 147: 610–617.
56. Dickey W, Hughes DF and McMillan SA. Patients with serum IgA endomysial antibodies and intact duodenal villi: Clinical characteristics and management options. Scand J Gastroenterol 2005; 40: 1240–1243.
57. Biagi F, Trotta L, Alfano C, et al. Prevalence and natural history of potential celiac disease in adult patients. Scand J Gastroenterol 2013; 48: 537–542.
58. Zarkadas M, Cranney A, Case S, et al. The impact of a gluten-free diet on adults with coeliac disease: Results of a national survey. J Hum Nutr Diet 2006; 19: 41–49.
59. Lee AR, Ng DL, Zivin J, et al. Economic burden of a gluten-free diet. J Hum Nutr Diet 2007; 20: 423–430.
60. Hall NJ, Rubin G and Charnock A. Systematic review: Adherence to a gluten-free diet in adult patients with coeliac disease. Aliment Pharmacol Ther 2009; 30: 315–330.
61. Fabiani E, Taccari LM, Ratsch IM, et al. Compliance with gluten-free diet in adolescents with screeningdetected celiac disease: A 5-year follow-up study. J Pediatr 2000; 136: 841–843.
62. Shamir R, Yehezkely-Schildkraut V, Hartman C, et al. Population screening for celiac disease: Follow up of patients identified by positive serology. J Gastroenterol Hepatol 2007; 22: 532–535.
63. Vilppula A, Kaukinen K, Luostarinen L, et al. Clinical benefit of gluten-free diet in screen-detected older celiac disease patients. BMC Gastroenterol 2011; 11: 136.
64. Viljamaa M, Collin P, Huhtala H, et al. Is coeliac disease screening in risk groups justified? A fourteen-year followup with special focus on compliance and quality of life. Aliment Pharmacol Ther 2005; 22: 317–324.
65. Sategna-Guidetti C, Grosso S, Pulitano R, et al. Celiac disease and insulin-dependent diabetes mellitus. Screening in an adult population. Dig Dis Sci 1994; 39: 1633–1637.
66. Kaukinen K, Salmi J, Lahtela J, et al. No effect of glutenfree diet on the metabolic control of Type 1 diabetes in patients with diabetes and celiac disease. Retrospective and controlled prospective survey. Diabetes Care 1999; 22: 1747–1748.
67. Sanchez-Albisua I, Wolf J, Neu A, et al. Coeliac disease in children with Type 1 diabetes mellitus: The effect of the gluten-free diet. Diabet Med 2005; 22: 1079–1082.
68. Wild D, Robins GG, Burley VJ, et al. Evidence of high sugar intake, and low fibre and mineral intake, in the gluten-free diet. Aliment Pharmacol Ther 2010; 32: 573–581.
69. Mariani P, Viti MG, Montuori M, et al. The gluten-free diet: A nutritional risk factor for adolescents with celiac disease? J Pediatr Gastroenterol Nutr 1998; 27: 519–523.
70. Midhagen G and Hallert C. High rate of gastrointestinal symptoms in celiac patients living on a gluten-free diet: Controlled study. Am J Gastroenterol 2003; 98: 2023–2026.
71. Dickey W and Kearney N. Overweight in celiac disease: Prevalence, clinical characteristics and effect of a glutenfree diet. Am J Gastroenterol 2006; 101: 2356–2359.
72. Kabbani TA, Goldberg A, Kelly CP, et al. Body mass index and the risk of obesity in coeliac disease treated with the gluten-free diet. Aliment Pharmacol Ther 2012; 35: 723–729.
73. Rampertab SD, Pooran N, Brar P, et al. Trends in the presentation of celiac disease. Am J Med 2006; 119: 355e9–14.
74. Collin P, Huhtala H, Virta L, et al. Diagnosis of celiac disease in clinical practice: Physician’s alertness to the condition essential. J Clin Gastroenterol 2007; 41: 152–156.
75. Vilppula A, Kaukinen K, Luostarinen L, et al. Increasing prevalence and high incidence of celiac disease in elderly people: A population-based study. BMC Gastroenterol 2009; 9: 49.
76. Sanders DS, Carter MJ, Hurlstone DP, et al. Association of adult coeliac disease with irritable bowel syndrome: A case-control study in patients fulfilling ROME II criteria referred to secondary care. Lancet 2001; 358: 1504–1508.
77. Verdu EF, Armstrong D and Murray JA. Between celiac disease and irritable bowel syndrome: The ‘no man’s land’ of gluten sensitivity. Am J Gastroenterol 2009; 104: 1587–1594.
78. Van der Windt DA, Jellema P, Mulder CJ, et al. Diagnostic testing for celiac disease among patients with abdominal symptoms: A systematic review. JAMA 2010; 303: 1738–1746.
79. Rosen A, Sandstrom O, Carlsson A, et al. Usefulness of symptoms to screen for celiac disease. Pediatrics 2014; 133: 211–218.
80. Green PHR, Stavropoulos SN, Panagi SG, et al. Characteristics of adult celiac disease in the USA: Results of a national survey. Am J Gastroenterol 2001; 96: 126–131.
81. Cranney A, Zarkadas M, Graham ID, et al. The Canadian Celiac Health Survey. Dig Dis Sci 2007; 52: 1087–1095.
82. Hauser W, Stallmach A, Caspary WF, et al. Predictors of reduced health-related quality of life in adults with coeliac disease. Aliment Pharmacol Ther 2007; 25: 569–578.
83. Gray AM and Papanicolas IN. Impact of symptoms on quality of life before and after diagnosis of coeliac disease: Results from a UK population survey. BMC Health Serv Res 2010; 10: 105.
84. Rodrigo-Saez L, Fuentes-Alvarez D, Perez-Martinez I, et al. Differences between pediatric and adult celiac disease. Rev Esp Enferm Dig 2011; 103: 238–244.
85. Norstrom F, Lindholm L, Sandstrom O, et al. Delay to celiac disease diagnosis and its implications for healthrelated quality of life. BMC Gastroenterol 2011; 11: 118.
86. Biagi F, Schiepatti A, Malamut G, et al. PROgnosticating COeliac patieNts SUrvivaL: The PROCONSUL score. PLoS One 2014; 9: e84163.
87. Canavan C, Logan RF, Khaw KT, et al. No difference in mortality in undetected coeliac disease compared with the general population: A UK cohort study. Aliment Pharmacol Ther 2011; 34: 1012–1019.
88. Lohi S, Maki M, Rissanen H, et al. Prognosis of unrecognized coeliac disease as regards mortality: A population- based cohort study. Ann Med 2009; 41: 508–515.
89. Godfrey JD, Brantner TL, Brinjikji W, et al. Morbidity and mortality among older individuals with undiagnosed celiac disease. Gastroenterology 2010; 139: 763–769.
90. Metzger MH, Heier M, Maki M, et al. Mortality excess in individuals with elevated IgA anti-transglutaminase antibodies: The KORA/MONICA Augsburg cohort study 1989–1998. Eur J Epidemiol 2006; 21: 359–365.
91. Virta LJ, Kaukinen K and Collin P. Incidence and prevalence of diagnosed coeliac disease in Finland: Results of effective case finding in adults. Scand J Gastroenterol 2009; 44: 933–938.
92. Cosnes J, Cellier C, Viola S, et al. Incidence of autoimmune diseases in celiac disease: Protective effect of the gluten-free diet. Clin Gastroenterol Hepatol 2008; 6: 753–758.
93. Ventura A, Neri E, Ughi C, et al. Gluten-dependent diabetes-related and thyroid-related autoantibodies in patients with celiac disease. J Pediatr 2000; 137: 263–265.
94. Toscano V, Conti FG, Anastasi E, et al. Importance of gluten in the induction of endocrine autoantibodies and organ dysfunction in adolescent celiac patients. Am J Gastroenterol 2000; 95: 1742–1748.
95. Bakker SF, Tushuizen ME, Stokvis-Brantsma WH, et al. Frequent delay of coeliac disease diagnosis in symptomatic patients with Type 1 diabetes mellitus: Clinical and genetic characteristics. Eur J Intern Med 2013; 24: 456–460.
96. Mollazadegan K, Sanders DS, Ludvigsson J, et al. Long-term coeliac disease influences risk of death in patients with Type 1 diabetes. J Intern Med 2013; 274: 273–280.
97. Mollazadegan K, Kugelberg M, Montgomery SM, et al. A population-based study of the risk of diabetic retinopathy in patients with Type 1 diabetes and celiac disease. Diabetes Care 2013; 36: 316–321.
98. Mollazadegan K, Fored M, Lundberg S, et al. Risk of renal disease in patients with both Type 1 diabetes and coeliac disease. Diabetologia 2014; 57: 1339–1345.
99. Hansen D, Brock-Jacobsen B, Lund E, et al. Clinical benefit of a gluten-free diet in Type 1 diabetic children with screening-detected celiac disease: A populationbased screening study with 2 years’ follow-up. Diabetes Care 2006; 29: 2452–2456.
100. Leeds JS, Hopper AD, Hadjivassiliou M, et al. High prevalence of microvascular complications in adults with Type 1 diabetes and newly diagnosed celiac disease. Diabetes Care 2011; 34: 2158–2163.
101. Tio M, Cox MR and Eslick GD. Meta-analysis: Coeliac disease and the risk of all-cause mortality, any malignancy and lymphoid malignancy. Aliment Pharmacol Ther 2012; 35: 540–551.
102. Elfstrom P, Granath F, Ye W, et al. Low risk of gastrointestinal cancer among patients with celiac disease, inflammation, or latent celiac disease. Clin Gastroenterol Hepatol 2012; 10: 30–36.
103. Green PH, Fleischauer AT, Bhagat G, et al. Risk of malignancy in patients with celiac disease. Am J Med 2003; 115: 191–195.
104. West J, Logan RF, Smith CJ, et al. Malignancy and mortality in people with coeliac disease: Population based cohort study. Brit Med J 2004; 329: 716–719. 118
105. Ludvigsson JF, West J, Ekbom A, et al. Reduced risk of breast, endometrial, and ovarian cancer in women with celiac disease. Int J Cancer 2012; 131: E244–E250.
106. Lohi S, Maki M, Montonen J, et al. Malignancies in cases with screening-identified evidence of coeliac disease: A long-term population-based cohort study. Gut 2009; 58: 643–647.
107. Elli L, Contiero P, Tagliabue G, et al. Risk of intestinal lymphoma in undiagnosed coeliac disease: Results from a registered population with different coeliac disease prevalence. Dig Liver Dis 2012; 44: 743–747.
108. Catassi C, Fabiani E, Corrao G, et al. Risk of non- Hodgkin lymphoma in celiac disease. JAMA 2002; 287: 1413–1419.
109. Johnston SD and Watson RG. Small bowel lymphoma in unrecognized coeliac disease: A cause for concern? Eur J Gastroenterol Hepatol 2000; 12: 645–648.
110. Grainge MJ, West J, Solaymani-Dodaran M, et al. The long-term risk of malignancy following a diagnosis of coeliac disease or dermatitis herpetiformis: A cohort study. Aliment Pharmacol Ther 2012; 35: 730–739.
111. Card TR, West J and Holmes GK. Risk of malignancy in diagnosed coeliac disease: A 24-year prospective, population-based, cohort study. Aliment Pharmacol Ther 2004; 20: 769–775.
112. Silano M, Volta U, Vincenzi AD, et al. Effect of a gluten-free diet on the risk of enteropathy-associated T-cell lymphoma in celiac disease. Dig Dis Sci 2008; 53: 972–976.
113. Olen O, Askling J, Ludvigsson JF, et al. Coeliac disease characteristics, compliance to a gluten free diet and risk of lymphoma by subtype. Dig Liver Dis 2011; 43: 862–868.
114. Ciacci C, Cirillo M, Auriemma G, Di Dato G, Sabbatini F and Mazzacca G. Celiac disease and pregnancy outcome. Am J Gastroenterol 1996; 91: 718–722.
115. Martinelli P, Troncone R, Paparo F, et al. Coeliac disease and unfavourable outcome of pregnancy. Gut 2000; 46: 332–335.
116. Khashan AS, Henriksen TB, Mortensen PB, et al. The impact of maternal celiac disease on birthweight and preterm birth: A Danish population-based cohort study. Hum Reprod 2010; 25: 528–534.
117. Ludvigsson JF, Montgomery SM and Ekbom A. Celiac disease and risk of adverse fetal outcome: A populationbased cohort study. Gastroenterology 2005; 129: 454–463.
118. Hogen Esch CE, Van Rijssen MJ, Roos A, et al. Screening for unrecognized coeliac disease in subfertile couples. Scand J Gastroenterol 2011; 46: 1423–1428.
119. Zugna D, Richiardi L, Akre O, et al. A nationwide population-based study to determine whether coeliac disease is associated with infertility. Gut 2010; 59: 1471–1475.
120. Tata LJ, Card TR, Logan RF, et al. Fertility and pregnancy- related events in women with celiac disease: A population-based cohort study. Gastroenterology 2005; 128: 849–855.
121. West J, Logan RF, Hill PG, et al. Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut 2003; 52: 960–965.
122. Lewis NR, Sanders DS, Logan RF, et al. Cholesterol profile in people with newly diagnosed coeliac disease: A comparison with the general population and changes following treatment. Br J Nutr 2009; 102: 509–513.
123. Olen O, Montgomery SM, Marcus C, et al. Coeliac disease and body mass index: A study of two Swedish general population-based registers. Scand J Gastroenterol 2009; 44: 1198–1206.
124. Ludvigsson JF, James S, Askling J, et al. Nationwide cohort study of risk of ischemic heart disease in patients with celiac disease. Circulation 2011; 123: 483–490.
125. Mustalahti K, Lohiniemi S, Collin P, et al. Glut en-free diet and quality of life in patients with screen-detected celiac disease. Eff Clin Pract 2002; 5: 105–113.
126. Nachman F, Maurino E, Vazquez H, et al. Quality of life in celiac disease patients: Prospective analysis on the importance of clinical severity at diagnosis and the impact of treatment. Dig Liver Dis 2009; 41: 15–25.
127. Kurppa K, Collin P, Sievanen H, et al. Gastrointestinal symptoms, quality of life and bone mineral density in mild enteropathic coeliac disease: A prospective clinical trial. Scand J Gastroenterol 2010; 45: 305–314.
128. Olsson C, Lyon P, Hornell A, et al. Food that makes you different: The stigma experienced by adolescents with celiac disease. Qual Health Res 2009; 19: 976–984.
129. Hallert C, Granno C, Hulten S, et al. Living with coeliac disease: Controlled study of the burden of illness. Scand J Gastroenterol 2002; 37: 39–42.
130. Fera T, Cascio B, Angelini G, et al. Affective disorders and quality of life in adult coeliac disease patients on a gluten-free diet. Eur J Gastroenterol Hepatol 2003; 15: 1287–1292.
131. Lee A and Newman JM. Celiac diet: Its impact on quality of life. J Am Diet Assoc 2003; 103: 1533–1535.
132. Dretzke J, Cummins C, Sandercock J, et al. Autoantibody testing in children with newly diagnosed Type 1 diabetes mellitus. Health Technol Assess 2004; 8: 3-11, 1–183.
133. Hershcovici T, Leshno M, Goldin E, et al. Cost effectiveness of mass screening for coeliac disease is determined by time-delay to diagnosis and quality of life on a gluten-free diet. Aliment Pharmacol Ther 2010; 31: 901–910.
134. Shamir R, Hernell O and Leshno M. Cost-effectiveness analysis of screening for celiac disease in the adult population. Med Decis Making 2006; 26: 282–293.
135. Sanders DS, Hurlstone DP, Stokes RO, et al. Changing face of adult coeliac disease: Experience of a single university hospital in South Yorkshire. Postgrad Med J 2002; 78: 31–33.
136. Park KT, Tsai R, Wang L, et al. Cost-effectiveness of universal serologic screening to prevent nontraumatic hip and vertebral fractures in patients with celiac disease. Clin Gastroenterol Hepatol 2013; 11: 645–653.
137. Rubio-Tapia A, Van Dyke CT, Lahr BD, et al. Predictors of family risk for celiac disease: A population- based study. Clin Gastroenterol Hepatol 2008; 6: 983–987.
138. Rostom A, Murray JA and Kagnoff MF. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology 2006; 131: 1981–2002.
139. Greco L, Romino R, Coto I, et al. The first large population- based twin study of coeliac disease. Gut 2002; 50: 624–628.
140. Bao F, Yu L, Babu S, et al. One third of HLA DQ2 homozygous patients with Type 1 diabetes express celiac disease-associated transglutaminase autoantibodies. J Autoimmun 1999; 13: 143–148.
141. Ludvigsson JF, Ludvigsson J, Ekbom A, et al. Celiac disease and risk of subsequent Type 1 diabetes: A general population cohort study of children and adolescents. Diabetes Care 2006; 29: 2483–2488.
142. Van Autreve JE, Weets I, Gulbis B, et al. The rare HLADQA1* 03-DQB1*02 haplotype confers susceptibility to Type 1 diabetes in whites and is preferentially associated with early clinical disease onset in male subjects. Hum Immunol 2004; 65: 729–736.
143. Poulain C, Johanet C, Delcroix C, et al. Prevalence and clinical features of celiac disease in 950 children with Type 1 diabetes in France. Diabetes Metab 2007; 33: 453–458.
144. Skovbjerg H, Tarnow L, Locht H, et al. The prevalence of coeliac disease in adult Danish patients with Type 1 diabetes with and without nephropathy. Diabetologia 2005; 48: 1416–1417.
145. Fine KD. The prevalence of occult gastrointestinal bleeding in celiac sprue. N Engl J Med 1996; 334: 1163–1167.
146. Ransford RA, Hayes M, Palmer M, et al. A controlled, prospective screening study of celiac disease presenting as iron deficiency anemia. J Clin Gastroenterol 2002; 35: 228–233.
147. Ford AC, Chey WD, Talley NJ, et al. Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: Systematic review and meta-analysis. Arch Intern Med 2009; 169: 651–658.
148. Bonamico M, Mariani P, Danesi HM, et al. Prevalence and clinical picture of celiac disease in Italian down syndrome patients: A multicenter study. J Pediatr Gastroenterol Nutr 2001; 33: 139–143.
149. Wouters J, Weijerman ME, Van Furth AM, et al. Prospective human leukocyte antigen, endomysium immunoglobulin A antibodies, and transglutaminase antibodies testing for celiac disease in children with Down syndrome. J Pediatr 2009; 154: 239–242.
150. Gale L, Wimalaratna H, Brotodiharjo A, et al. Down’s syndrome is strongly associated with coeliac disease. Gut 1997; 40: 492–496.
151. Bonamico M, Pasquino AM, Mariani P, et al. Prevalence and clinical picture of celiac disease in Turner syndrome. J Clin Endocrinol Metab 2002; 87: 5495–5498.
152. Ivarsson SA, Carlsson A, Bredberg A, et al. Prevalence of coeliac disease in Turner syndrome. Acta Paediatr 1999; 88: 933–936.
153. Swigonski NL, Kuhlenschmidt HL, Bull MJ, et al. Screening for celiac disease in asymptomatic children with Down syndrome: Cost-effectiveness of preventing lymphoma. Pediatrics 2006; 118: 594–602.
154. West J, Logan RF, Card TR, et al. Fracture risk in people with celiac disease: A population-based cohort study. Gastroenterology 2003; 125: 429–436.
155. Vestergaard P and Mosekilde L. Fractures in patients with hyperthyroidism and hypothyroidism: A nationwide follow-up study in 16,249 patients. Thyroid 2002; 12: 411–419.
156. Ludvigsson JF, Michaelsson K, Ekbom A, et al. Coeliac disease and the risk of fractures: A general populationbased cohort study. Aliment Pharmacol Ther 2007; 25: 273–285.
157. NICE Coeliac disease. Recognition and assessment of celiac disease. London: NICE.